Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Alpha-D-Lactose Monohydrate

    • Product Name Alpha-D-Lactose Monohydrate
    • Alias Lactose Monohydrate
    • Einecs 200-559-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    522952

    Chemicalname Alpha-D-Lactose Monohydrate
    Casnumber 5989-81-1
    Molecularformula C12H22O11·H2O
    Molarmass 360.31 g/mol
    Appearance White crystalline powder
    Solubilityinwater 18.9 g/100 mL at 25°C
    Meltingpoint 202°C (decomposes)
    Odor Odorless
    Taste Slightly sweet
    Density 1.545 g/cm³
    Ph 5.0–7.0 (10% solution)
    Stability Stable under recommended storage conditions
    Storageconditions Store in a cool, dry, well-ventilated place
    Synonyms Lactose monohydrate; Milk sugar
    Ecnumber 200-559-2

    As an accredited Alpha-D-Lactose Monohydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Alpha-D-Lactose Monohydrate, 500g, is packaged in a sealed, white HDPE bottle with a tamper-evident cap and labeled details.
    Shipping Alpha-D-Lactose Monohydrate is typically shipped in tightly sealed containers to prevent moisture absorption and contamination. Store and transport under cool, dry conditions, away from incompatible substances. Ensure appropriate labeling, and handle following standard chemical safety guidelines. Packaging usually complies with regulations for non-hazardous, food-grade chemicals. Avoid exposure to heat or direct sunlight.
    Storage Alpha-D-Lactose Monohydrate should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from moisture and incompatible substances. Protect the chemical from direct sunlight and sources of heat. Store at room temperature, ideally between 15–25°C (59–77°F). Ensure good labeling and limit exposure to airborne dust to maintain product quality and safety.
    Application of Alpha-D-Lactose Monohydrate

    Applications of Alpha-D-Lactose Monohydrate in Industrial Manufacturing

    As the direct manufacturer of Alpha-D-Lactose Monohydrate, we support a range of industrial production lines by supplying high-purity lactose essential for specialized downstream processes. This material serves as a functional component in critical applications, each with its own formulation requirements, compliance standards, and integrated process roles. The following sections detail specific industrial scenarios where Alpha-D-Lactose Monohydrate is a proven ingredient, focusing on compliance, dosing precision, processing stages, and the nature of final products delivered by end-users.

    1. Pharmaceutical Solid Oral Dosage Forms

    In pharmaceutical manufacturing, Alpha-D-Lactose Monohydrate functions primarily as a direct compression and wet granulation filler-binder in solid oral dosage forms. Its particle size distribution and flowability make it a key excipient for achieving dose uniformity, tablet hardness, and disintegration performance across both immediate-release and controlled-release drug formulations. Pharmaceutical customers require consistent physical and chemical properties for GMP-validated processes, and the volume used varies by active ingredient characteristics and process type.

    Industry compliance standards

    • Meet latest editions of USP-NF (U.S. Pharmacopeia), EP (European Pharmacopoeia), JP (Japanese Pharmacopoeia)
    • Conforms to ICH Q7 guidelines for GMP compliance
    • Regulatory documentation: DMF Type IV (USA), CEP (Europe)
    • Meets US FDA 21 CFR Part 210/211 requirements for pharmaceutical excipients

    Typical usage ratio

    • Commonly 20–85% of tablet/capsule weight, adjusted for API load, compressibility, and dissolution profile
    • Low-dose actives may require upper range to ensure blend uniformity
    • Modified release matrices typically use 15–40%
    • Specific ratios determined by blend flow and compaction characteristics

    Downstream process integration

    • Blending with active pharmaceutical ingredients in high-shear or planetary mixers
    • Feeds directly into dry granulation (roller compaction) or wet granulation (fluid bed) steps
    • Transfers to tablet press for direct compression or after granulation drying
    • Capsule filling operations use lactose as excipient for low-density actives

    Final product types

    • Immediate-release tablets (painkillers, antibiotics, antihistamines etc.)
    • Modified/sustained release tablets
    • Hard gelatin capsules containing powdered blends
    • Oral dispersible tablets and lozenges

    2. Infant Formula and Specialized Dairy Blends

    Alpha-D-Lactose Monohydrate is a principal carbohydrate source in infant formula and special medical nutrition blends. Its composition closely mimics the lactose profile of human milk, facilitating easy digestion and infant gut microflora development. High purity and microbiological criteria help formula manufacturers achieve both nutritional adequacy and food safety assurance. Strict compliance and controlled blending support finished powders tailored for sensitive populations.

    Industry compliance standards

    • Codex Alimentarius Standard for Infant Formula (CODEX STAN 72-1981)
    • EU Regulation (EU) No 609/2013 on food for infants and young children
    • China National Food Safety Standard GB 10765 (Infant formula)
    • ISO 22000 Food Safety Management; FSSC 22000; HACCP

    Typical usage ratio

    • 35–55% of total carbohydrate content; may reach up to 60% in non-hydrolyzed formulas
    • Exact inclusion depends on product goal (standard, low-lactose, or lactose-free formula)
    • Medical formulas for lactose-intolerant use lower ratios or substitute partially
    • Adjusted to balance osmolality and nutrient fortification requirements

    Downstream process integration

    • Dry blending with milk powders, whey proteins, vegetable oils, and micronutrients
    • Homogenized and pasteurized in liquid manufacturing stages, then spray dried
    • Lactose dissolves in pre-mix tanks before thermal processing
    • Quality-controlled sieving prior to packaging to ensure consistent dispersibility

    Final product types

    • Infant formula powder cans and sachets
    • Follow-on formula and growing-up milk powders
    • Specialized formulas (hypoallergenic, low-protein, metabolic disorder blends)
    • Premature infant and pediatric medical nutrition powders

    3. Injection-Grade Lyophilized Biologics

    Sterile manufacturing of injection-grade lyophilized (freeze-dried) biologics and peptides relies on high-purity lactose as a bulking agent and stabilizer. The material preserves protein structure during freezing and drying, ensuring critical quality attributes in finished vials. Stringent microbial and endotoxin limits, along with batch-to-batch consistency, directly impact downstream lyophilization yield and reconstitution clarity.

    Industry compliance standards

    • USP and EP specifications for injectable grade lactose
    • GMP certification ISO 9001:2015 and PIC/S Guide to GMP for sterile pharmaceuticals
    • ICH Q6A guidelines for specification of biotechnological products
    • Endotoxin limit: USP <85> Bacterial Endotoxins, typically <0.25 EU/g

    Typical usage ratio

    • Filling volume: 5–40 mg per vial, typically 1–9% w/v of solution before freeze-drying
    • Adjusted based on protein, peptide, or vaccine bulking needs and target cake structure
    • Minimum necessary to maintain physical stability without interfering with reconstitution
    • Varies per biologic type and container size

    Downstream process integration

    • Dissolved in water for injection during formulation of bulk solution
    • Filtered through sterilizing-grade membranes before aseptic vial-filling
    • Vials loaded into lyophilizer for controlled freeze-drying cycle
    • Requalification of lactose source with each process validation batch

    Final product types

    • Lyophilized protein and peptide therapeutics in sterile vials
    • Monoclonal antibody products designed for reconstitution
    • Pediatric and adult vaccine powder formulations
    • Diagnostic kit lyophilized reagents

    4. Food Ingredient for Bakery and Confectionery

    Food manufacturers add Alpha-D-Lactose Monohydrate to bakery, confectionery, and chocolate production to control texture, sweetness, and Maillard color development. It enhances browning in baked items and modulates crystallization in chocolate, introducing consistent physical and sensory qualities. Producers rely on strict food safety documentation and batch monitoring to meet regulatory demands and optimize formulation for each product category.

    Industry compliance standards

    • Compliant with FCC (Food Chemicals Codex) purity requirements
    • Codex Alimentarius General Standard for Food Additives (GSFA)
    • EU Food Additives Regulation (EC) No 1333/2008
    • Alignment with ISO 22000 and documented allergen handling

    Typical usage ratio

    • 2–12% by recipe mass in bakery dough and batter mixes, influenced by desired crust color and texture
    • Up to 10% in chocolate fillings to adjust crystallization and mouthfeel
    • Range varies depending on sugar replacement and moisture content demands
    • Precise dosage checked against total carbohydrate profile of the finished good

    Downstream process integration

    • Direct addition to dry blend stages for baking mixes, or emulsification into fats for confectionery
    • Combined with other sweeteners or milk solids in multi-step creaming or tempering
    • Plays a part in proofing behavior of yeast-raised goods by controlling osmolality
    • Screened for homogeneity before extrusion or molding steps

    Final product types

    • Sweet and savory baked breads, rolls, and crackers
    • Milk chocolate bars, filled chocolates and pralines
    • Wafers, biscuits, and industrial cookies
    • Cake premixes for retail and catering

    5. Fermentation Nutrient in Industrial Microbial Production

    Biotechnology and fermentation plants incorporate Alpha-D-Lactose Monohydrate as a carbon source and nutrient regulator in microbial media. It houses beneficial properties for inducing secondary metabolite synthesis, such as antibiotics or enzymes, facilitating targeted yield increases and consistent process kinetics. Consistent physical properties and trace contaminant controls contribute to batch quality and bioreactor productivity.

    Industry compliance standards

    • Follows ISO 9001:2015 for ingredient traceability and QC documentation
    • Non-GMO certification where required for downstream product assurance
    • Complies with EU Regulation (EC) No 1069/2009 for biotech feedstocks
    • Assures absence of prohibited contaminants per pharmacopeia residue limits when used in regulated bioprocesses

    Typical usage ratio

    • 5–40 g/L in standard microbial fermentation broths for actinomycetes (e.g., antibiotic manufacturing)
    • Concentrations tailored by microorganism strain, target yield, fermenter scale, and metabolic pathway optimization
    • Screened pilot studies to determine maximum lactose uptake without inhibiting growth
    • Reduced or omitted for processes relying on alternative carbon sources (if specified in process QA)

    Downstream process integration

    • Dissolved in seed medium and main fermenter charge solutions prior to sterilization
    • Automatically dosed into fed-batch fermentation via peristaltic or mass flow controllers
    • Monitored using real-time substrate consumption analytics to maintain growth kinetics
    • Culture supernatant processed by downstream separation, concentration, and purification steps

    Final product types

    • Bulk antibiotic ingredient powders (e.g., cephalosporin, streptomycin)
    • Microbial enzyme concentrates and technical enzyme powders
    • Food-grade and pharmaceutical amino acid solutions
    • Starter cultures for dairy fermentation processes
    Free Quote

    Competitive Alpha-D-Lactose Monohydrate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Alpha-D-Lactose Monohydrate: Quality Born from Proven Manufacturing

    Alpha-D-Lactose Monohydrate often goes unnoticed outside the pharmaceutical and food industries, but those of us on the manufacturing floor see it every day—in raw form, in the precise crystalline shapes, and in the massive shipping containers headed across the world. We pour attention into this sugar, derived from whey, filtering, refining, crystallizing, and drying until we hit the purity grade our partners have trusted for years. Our typical model falls in line with the 200 mesh grade, where a gritty off-white powder transforms into a usability asset. The details we watch daily—particle size, bulk density, moisture content—shape every order we fill.

    Alpha-D-Lactose Monohydrate, with its empirical formula C12H22O11·H2O, shows consistency batch-to-batch, but making it reliable enough for someone’s medicine or dairy-free chocolate doesn’t happen by accident. Skilled operators run calibrated sieves to keep particle size in spec. Our chromatography and titration procedures ensure nobody finds themselves facing odd flavors, unexpected reactivity, or unexplained color changes in their applications. Regulatory standards—like those coming from the USP, EP, and JP—act less as abstract compliance targets and more as the due north on our production compass.

    Building Quality Through Process

    Over the past decade, consumer attitudes and technological advancements have changed lactose demand forever. The food industry pushes us to keep up with rapid product cycles, while pharmaceutical clients expect ingredients that dissolve predictably and compress cleanly into tablets, even at scale. Our teams have worked side by side with engineers and QA staff in both sectors, watching how our product runs on their lines, and learning from every batch that sticks, compacts, or refuses to blend. Those experiences drove us to refine our crystallization and drying steps, pushing out fines and controlling agglomeration, so clients see fewer production halts and more reliable downstream results.

    Each shipment heading out needs to meet moisture specs that keep long-term stability predictable, especially for medicine formulators. Residual water plays a lasting role, impacting not just shelf life but also how lactose interacts with actives or flavors. For us, batch testing isn’t a once-a-week event; it’s stitched into each lot, and retesting happens with any hint of deviation. Sometimes the biggest differences from product to product come down to subtle numbers: a little extra moisture drives up caking, or a shift in density ruins batch consistency. We’ve lost market share and won orders based on details like this—that’s how sharp the competition has become.

    Applications Shaped by Performance

    Pharmaceutical manufactories care about single-digit purity numbers because small molecule excipients affect drug bioavailability and formulation reproducibility. Engineers working in direct compression want lactose that stays free-flowing right into the tableting press, without causing tool wear or uneven dosing. Alpha-D-Lactose Monohydrate brings a measurably consistent flow, and after years of working alongside their teams, we've learned that adjusting sieve and drying parameters means fewer disruptions in downstream blending operations. This lets customers hold tighter stacking schedules and keep validation work simple, as every batch shows up behaving like the last one.

    Our food industry partners approach lactose from a different angle. Texture and mouthfeel matter just as much as sweetness or caloric content, so food technologists need the particle size and purity to stay inside well-defined limits. In some cases, a coarser cut gives ice cream its body or baked goods just the right crumb. On the other hand, finer lactose powder brings rapid dissolution for drink mixes or flavor blends. Predictable color and neutral aroma arise directly from the control we maintain during purification, so formulators don’t need to mask off-flavors or re-balance recipes unexpectedly.

    Specification and Traceability: Real Value Beyond the Label

    A decade back, traceability just meant keeping batch numbers clear, but modern buyers and regulators expect granular visibility. Auditors from international clients walk our floors to watch documentation, pull samples, and quiz technicians—the systems either stand up or they don’t. Every test point we add to the line becomes a record, and every adjustment is traceable to the raw milk delivered by local farmers. We’ve invested heavily in digital logging and remote monitoring, linking batch release certificates to analytical data. That’s not a marketing flourish; a single misstep can shut down entire customer lines or call back products from thousands of shelves. Being able to answer a formulator’s question about trace levels of proteins or potential allergens means real-world business saved.

    Differences between Alpha-D-Lactose Monohydrate and regular anhydrous forms get overlooked at the procurement desk, but on the plant floor, the results are hard to miss. Monohydrate grades offer a less hygroscopic profile and more predictable drying behavior, making the product friendlier to storage in varied climates. This is especially significant for export, as containers roll through humid ports or sit in warehouses without advanced climate control. Our customers have reported fewer complaints about lumping or discoloration in their international inventory, thanks to the careful water control locked into our monohydrate crystals. When it comes to process integration, the right starting materials mean less downtime chasing variability.

    User Experience Shapes Product Decisions

    One silent challenge we encounter comes from how end-users handle and store product after delivery. Customers with automated feeding systems notice even minor deviations in bulk density or particle cohesiveness. In our early years, a shipment delay led to the discovery that certain storage bins led to caking, which wouldn’t have come up in small-scale batch testing. That incident changed both our drying curve and the packing specification. Since then, any feedback that hints at process snags makes its way back to our development team, and we continue to customize operational parameters based on those reports. Our work does not finish at the shipping dock.

    Packaging can often be overlooked, but for sensitive pharmaceutical or export orders, it becomes a determining factor in shelf life and ease of use. Our current packs range from multi-layered paper sacks with custom liners to bulk bags equipped with humidity indicators, born from direct collaboration with users who’ve experienced product loss or shifts in performance due to packaging breakdowns. We see growing interest in eco-friendly materials, and we have initiated supplier vetting to ensure biopolymer liners maintain material integrity under real transport and warehouse conditions. Switching suppliers taught us that a few microns less of film thickness in a liner may translate into months knocked off the useable life of lactose in a wet warehouse.

    Comparisons With Other Lactose Grades

    Every product line, from instantized food powders to high-potency pharmaceuticals, calls for a slightly different lactose profile. Monohydrate forms deliver defined crystalline water content, making them preferable for certain tablet dissolution timelines. In contrast, anhydrous lactose, with its lack of bound water, dissolves more quickly, making it attractive where speed of action trumps storage concerns. Spray-dried grades can solve issues for wet granulation or direct compression lines, but they demand even closer environmental controls and stricter blending discipline.

    Plant engineers who’ve switched between monohydrate and anhydrous forms notice the practical difference right away. On one job, we spent months working alongside a pharmaceutical customer who shifted to monohydrate to address capping in their compression process. The extra water molecule seemed small on paper, but it stabilized flow enough to prevent sticking and scrap losses. Food producers looking for clean-label claims turn to monohydrate for its simple derivation from milk, but want confirmation of absent contaminants or off-flavors—something that natural dairy compositions sometimes complicate. We built scaffolding in our testing regime to document trace protein and fat content, so their claims could withstand regulatory scrutiny.

    Global Market and Regulatory Drivers

    Demand for Alpha-D-Lactose Monohydrate continues to climb, especially with new pharmaceuticals coming online and functional foods carving out ever-broader shelves in global supermarkets. Emerging economies are building manufacturing capacity and looking for consistent ingredient supplies, not only for finished product exports but also for their growing domestic markets. Regulatory expectations travel faster than ever; what passes for compliance this year in Europe or the United States becomes the entry point for business in Southeast Asia or Africa the next. Our on-site compliance process audits, regular reference batch archiving, and real-time method updates all trace back to lessons learned from failed import clearances or delayed registration.

    The transition to new compendia editions or updated food regulations feels less like periodic spring cleaning and more like an ongoing relay. Each time the pharmacopeias update, analytical reference methods shift, or “nutrient profile” frameworks get revised, we invest time recalibrating both instrumentation and operator training. It’s not theory—early notice about a minimum particle size change saved us from producing and storing out-of-spec lactose, which could have seated product recalls. Investing in high-resolution analyzers and more robust QA training produces a return that sales volume alone cannot measure. Decision makers in our plant recall specific situations where unplanned downtime and shipment holds taught us the price of overlooking one line of a compendial revision.

    Supply Chain Realities and Risk Management

    Anyone inside a production organization walking the morning floor understands how narrow the margin of error can be. Supply chain interruptions—often invisible to the end user—send ripples through operations. Source variation in raw milk, shifts in regional environmental controls, or even sporadic labor actions demand contingency planning. We’ve built partnerships with multiple dairy co-ops to ensure year-round stable supply, and invested in buffer capacity, so our clients aren’t seeing sudden outages. This approach costs more, but our partners find value in shipments arriving on-schedule without frantic reworking or quality downgrades.

    Shipping finished lactose as a food ingredient requires more than just reliable inventory; temperature swings, humidity spikes, and long customs holds present new challenges every season. We learned years ago that packing and transport must evolve with each new destination, not just at the request of a customer but by anticipating documented risks. Our export managers, tasked with tracing spoilage complaints back to the source, introduced temperature-logging systems and modified-atmosphere packaging. These changes came straight from the realities of containers sitting on a hot dock in Mumbai or in a cold snap in Eastern Europe.

    Pace of Innovation, Room for Improvement

    Every year, R&D teams push us to revisit old assumptions. Tablet technology or protein-fortified foods may look established, but as soon as a customer unveils a new dosing requirement or shelf-life goal, we face the challenge of tweaking manufacturing lines, scaling up pilot runs, and recalibrating test methods. Basket-driven granulators and inline dispersion monitors create deeper insight into how each adjustment in particle profile echoes downstream. It’s easy to underestimate the complexity until an unexpected shift in compaction pressure or flow halts production on a customer’s side—then every metric gets re-examined.

    There is always a tension between new product features and the foundational qualities that keep lactose trustworthy. Pushing innovation doesn’t mean sacrificing the traditions and controls that have built reputation over years. We weigh every suggested pesticide analysis, every microbial risk control protocol, and every new process analytical technology by seeing how it affects users. Pulling in feedback from plant visits and on-site QA sessions, we improve process robustness and document every improvement cycle.

    Challenges Beyond Production: What Keeps Us Up at Night

    Environmental stewardship sits on the front burner now. Every kilogram of lactose begins with milk, tying us to agricultural practice and water use. Tightening wastewater regulations and embodied energy calculations push us to keep looking for new ways to recover energy and provide cleaner effluent. Our efforts recently focused on reusing process heat from crystallizers—an investment that took time to justify, but now helps keep our energy costs in check and our environmental metrics moving in the right direction.

    One segment of the market increasingly interested in our product consists of companies targeting allergen-constrained or vegan claims. The truth is, lactose comes from milk, and labeling integrity rests on keeping every step protected against cross-contact. We’ve invested in separated production streams for clients who need allergen management way beyond standard QC. The requests for animal-free lactose analogs push us to monitor developments in biotechnology—if and when true fermentation-based lactose becomes available at scale, we know it will change the market again.

    Partnership and Transparency Build Better Outcomes

    Working directly with food and drug manufacturers sharpens our understanding of what truly matters. Site visits, complaint investigations, and process reviews lift the veil on problems hard to spot from a QA desk or a supplier questionnaire. Real customer concerns may focus on invisible contaminants, minor texture changes, or unexpected system fouling—all challenges impossible to solve with generic responses or vague promises.

    The future for Alpha-D-Lactose Monohydrate will hold further challenges, but hands-on technical partnership means issues are flagged, solutions are shared, and every batch holds up to the knowledge that dozens of products—and thousands of end users—depend on our daily work. We measure our reputation not only by certificates of analysis but by calls from plant managers who return with new orders after problems get solved. As regulatory and performance pressures climb, that combination of experience, data, and responsiveness remains the core of what we deliver.